These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32405822)

  • 1. Leveraging Machine Learning to Identify Predictors of Receiving Psychosocial Treatment for Attention Deficit/Hyperactivity Disorder.
    Morrow AS; Campos Vega AD; Zhao X; Liriano MM
    Adm Policy Ment Health; 2020 Sep; 47(5):680-692. PubMed ID: 32405822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Predictors of Psychosocial Service Utilization in Youth with Attention-Deficit/Hyperactivity Disorder.
    Green CD; Langberg JM
    Clin Child Fam Psychol Rev; 2022 Jun; 25(2):356-375. PubMed ID: 34498154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
    Karic S; DesRosiers M; Mizrahi B; Zevallos J; Rodriguez P; Barengo NC
    Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with a medical home among children with Attention-Deficit Hyperactivity Disorder.
    Knapp CA; Hinojosa M; Baron-Lee J; Fernandez-Baca D; Hinojosa R; Thompson L
    Matern Child Health J; 2012 Dec; 16(9):1771-8. PubMed ID: 22143465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Predictors of Medication Use in Children with Attention-Deficit/Hyperactivity Disorder: Evidence from a Community-Based Longitudinal Study.
    Efron D; Gulenc A; Sciberras E; Ukoumunne OC; Hazell P; Anderson V; Silk TJ; Nicholson JM
    J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):50-57. PubMed ID: 30508385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A National Description of Treatment among United States Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Danielson ML; Visser SN; Chronis-Tuscano A; DuPaul GJ
    J Pediatr; 2018 Jan; 192():240-246.e1. PubMed ID: 29132817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention Deficit Hyperactivity Disorder in Childhood: Healthcare Use in a Danish Birth Cohort during the First 12 Years of Life.
    Laugesen B; Mohr-Jensen C; Boldsen SK; Jørgensen R; Sørensen EE; Grønkjær M; Rasmussen P; Lauritsen MB
    J Pediatr; 2018 Jun; 197():233-240. PubMed ID: 29580680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine-Learning prediction of comorbid substance use disorders in ADHD youth using Swedish registry data.
    Zhang-James Y; Chen Q; Kuja-Halkola R; Lichtenstein P; Larsson H; Faraone SV
    J Child Psychol Psychiatry; 2020 Dec; 61(12):1370-1379. PubMed ID: 32237241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.
    Farbstein I; Mansbach-Kleinfeld I; Auerbach JG; Ponizovsky AM; Apter A
    Isr Med Assoc J; 2014 Sep; 16(9):568-73. PubMed ID: 25351015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children.
    Kadesjö C; Hägglöf B; Kadesjö B; Gillberg C
    Dev Med Child Neurol; 2003 Oct; 45(10):693-9. PubMed ID: 14515941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Service use in children aged 6-8 years with attention deficit hyperactivity disorder.
    Efron D; Moisuc O; McKenzie V; Sciberras E
    Arch Dis Child; 2016 Feb; 101(2):161-5. PubMed ID: 26553911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patient-centered medical home, practice patterns, and functional outcomes for children with attention deficit/hyperactivity disorder.
    Toomey SL; Chan E; Ratner JA; Schuster MA
    Acad Pediatr; 2011; 11(6):500-7. PubMed ID: 21967721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent Class Analysis of ADHD Neurodevelopmental and Mental Health Comorbidities.
    Zablotsky B; Bramlett MD; Visser SN; Danielson ML; Blumberg SJ
    J Dev Behav Pediatr; 2018 Jan; 39(1):10-19. PubMed ID: 28902066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing medical homes for children with ADHD and asthma.
    Toomey SL; Homer CJ; Finkelstein JA
    Acad Pediatr; 2010; 10(1):56-63. PubMed ID: 20129482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment.
    Danielson ML; Claussen AH; Bitsko RH; Katz SM; Newsome K; Blumberg SJ; Kogan MD; Ghandour R
    J Clin Child Adolesc Psychol; 2024; 53(3):343-360. PubMed ID: 38778436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Child Attention-Deficit/Hyperactivity Disorder Treatment Guidelines in Medical Homes-Results from a National Survey.
    AlRasheed RM; Martin-Herz SP; Glidden DV; Okumura MJ
    J Dev Behav Pediatr; 2021 Dec; 42(9):695-703. PubMed ID: 34034294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Adverse Childhood Experiences and ADHD Diagnosis and Severity.
    Brown NM; Brown SN; Briggs RD; Germán M; Belamarich PF; Oyeku SO
    Acad Pediatr; 2017; 17(4):349-355. PubMed ID: 28477799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.